Jacobs Levy Equity Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$239K Sell
145,478
-562
-0.4% -$924 ﹤0.01% 966
2025
Q1
$266K Sell
146,040
-108,006
-43% -$197K ﹤0.01% 996
2024
Q4
$943K Sell
254,046
-63,598
-20% -$236K ﹤0.01% 722
2024
Q3
$1.02M Buy
317,644
+113,966
+56% +$365K ﹤0.01% 719
2024
Q2
$1.67M Sell
203,678
-20,541
-9% -$169K 0.01% 637
2024
Q1
$3.25M Sell
224,219
-201,615
-47% -$2.92M 0.01% 505
2023
Q4
$3.92M Buy
425,834
+215,895
+103% +$1.99M 0.02% 476
2023
Q3
$3.46M Sell
209,939
-150,920
-42% -$2.49M 0.02% 446
2023
Q2
$2.28M Sell
360,859
-57,390
-14% -$363K 0.01% 542
2023
Q1
$1.42M Buy
418,249
+2,914
+0.7% +$9.89K 0.01% 634
2022
Q4
$2.4M Buy
+415,335
New +$2.4M 0.02% 517
2021
Q1
Sell
-4,328
Closed -$618K 1024
2020
Q4
$618K Buy
+4,328
New +$618K 0.01% 818